Introduction:The Villalta scale is the endorsed tool to diagnose and grade the severity of post thrombotic syndrome (PTS); however, assessing presence and severity of PTS is time consuming and relies on both the clinician and patient's assessments. The patient reported Villalta scale version 2 (PRV2) is a visually assisted form that enables patients to self-assess presence and severity of PTS. Herein, we report on external validation of this tool. Methods: We assessed the agreement and kappa values of PRV2 to diagnose and assess severity of PTS compared with the original Villalta score in a cohort of 181 patients (196 limbs) who participated in the SAVER Pilot randomized control trial. Presence of PTS was defined as PRV2≥5 or a Villalta score≥5.Results: PTS prevalence was 42% using PRV2 and 33% using Villalta scale. The corresponding kappa and percentage agreement were 0.60 (95% CI: 0.49 to 0.71) and 81% (95% CI: 76 to 87) respectively. Kappa values and percentage agreements between PRV2 and Villalta scale increased
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.